Is intravesical BCG treatment necessary and/or sufficient?

Basit Öğe Kaydı
dc.contributor.authorEkici, Sinan
dc.contributor.authorTürker, Polat
dc.date.accessioned2022-05-11T14:36:57Z
dc.date.available2022-05-11T14:36:57Z
dc.date.issued2013
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı
dc.description.abstractIntravesical BCG treatment has been used over 3 decades in the treatment of non-muscle invasive bladder cancer. Although the exact mechanism of its action is not clear, its clinical efficiency has been proven. Numerous clinical trials are still trying to answer; which tumoral lesions this drug should be used for, which dosage is enough, which maintanence should be chosen and how long it should be continued. In this article the answers of these questions, with the current evidence, are summarised.
dc.identifier.endpage25
dc.identifier.issn2147-2270
dc.identifier.issue1en_US
dc.identifier.startpage22
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8499
dc.identifier.volume12
dc.identifier.wosWOS:000219391600006
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.institutionauthorTürker, Polat
dc.language.isotr
dc.publisherGalenos Yayincilik
dc.relation.ispartofUroonkoloji Bulteni-Bulletin of Urooncology
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectnon-muscle invasive bladder cancer
dc.subjectintravesical therapy
dc.subjectBCG
dc.subjectBacillus-Calmette-Guerin
dc.subjectSuperficial Bladder-Cancer
dc.subjectTransitional-Cell Carcinoma
dc.subjectT1 Papillary Carcinoma
dc.subjectHigh-Risk Ta
dc.subjectIn-Situ
dc.subjectMitomycin-C
dc.subjectEuropean Organization
dc.subjectUrothelial Carcinoma
dc.subjectUrinary-Bladder
dc.titleIs intravesical BCG treatment necessary and/or sufficient?
dc.typeReview Article

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu